Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents

Seizure

Volumn 19, Issue 3, 2010, Pages 195-197

  Mazurkiewicz Bełdzińska, Maria ^a   Szmuda, Marta ^a   Matheisel, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Idiopathic generalized epilepsy; Lamotrigine; Valproate

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CHILD; CHILDHOOD ABSENCE EPILEPSY; CHILDHOOD DISEASE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG WITHDRAWAL; EPILEPSY; EPILEPSY WITH TONIC CLONIC SEIZURE ON AWAKENING; FEMALE; HAIR LOSS; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC GENERALIZED EPILEPSY; JUVENILE ABSENCE EPILEPSY; JUVENILE MYOCLONIC EPILEPSY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYOCLONUS EPILEPSY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; STOMACH PAIN; TONIC CLONIC SEIZURE; WEIGHT GAIN;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; MALE; TRIAZINES; VALPROIC ACID;

EID: 77649191107     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.01.014     Document Type: Article

References (17)

1. Nicolson A., Appleton R.E., Chadwick D.W., and Smith D.F. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies. J Neurol Neurosurg Psychiatry 75 (2004) 75-79
2. Bergey G.K. Evidence-based treatment of idiopathic generalized epilepsies with new anti-epileptic drugs. Epilepsia 46 Suppl 9 (2005) 161-168
3. Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 369 (2007) 1016-1026
4. Wirrell E.C. Valproic acid-associated weight gain in older children and teens with epilepsy. Pediatr Neurol 28 (2003) 126-129
5. Diav-Citrin O., Shechtman S., Bar-Oz B., Cantrell D., Arnon J., and Ornoy A. Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect. CNS Drugs 22 (2008) 325-334
6. Wyszynski D.F., Nambisan M., Surve T., Alsdorf R.M., Smith C.R., and Holmes L.B. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64 (2005) 961-965
7. Vajda F.J., O'Brien T.J., Hitchcock A., Graham J., Cook M., Lander C., et al. Critical relationship between sodium valproate dose and human teratogenicity: Results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 11 (2004) 854-858
8. Vajda F.J., O'Brien T.J., Hitchcock A., Graham J., and Lander C. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J Clin Neurosci 10 (2003) 543-549
9. Morris G.L., Hammer A.E., Kustra R.P., and Messenheimer J.A. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study. Epilepsy Behav 5 (2004) 509-512
10. Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 5 (1996) 149-151
11. Messenheimer J. Efficacy and safety of lamotrigine in pediatric patients. J Child Neurol 17 Suppl 2 (2002) 2S34-32S42
12. Frank L.M., Enlow T., Holmes G.L., Manasco P., Concannon S., Chen C., et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 40 (1999) 973-979
13. Valencia I., Pinol-Ripoll G., Khurana D.S., Hardison H.H., Kothare S.V., Melvin J.J., et al. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Eur J Paediatr Neurol 13 (2009) 141-145
14. Curatolo P., Moavero R., Lo Castro A., and Cerminara C. Pharmacotherapy of idiopathic generalized epilepsies. Expert Opin Pharmacother 10 (2009) 5-17
15. Rambeck B., and Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinetics 25 (1993) 433-443
16. Carpay H.A., Arts W.F., Geerts A.T., Stroink H., Brouwer O.F., Boudewyn Peters A.C., et al. Epilepsy in childhood: an audit of clinical practice. Arch Neurol 55 (1998) 668-673
17. Montouris G., and Abou-Khalil B. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?. Epilepsia 50 Suppl 8 (2009) 16-20